About the Programme

The health system requires an increasing number of physician-scientists with a deep understanding of research and medicine to ensure that discoveries in fundamental research can reach clinical practice.

During their undergraduate and specialization studies, medical doctors receive some basic training in research. The objective of the PhD4MD Programme is to provide them with advanced hands-on training on the latest fields of research and cutting-edge technologies. 

Medical professionals who enroll in the PhD4MD programme will carry out a project in translational research jointly coordinated by a basic and a clinical research investigator, belonging to one of the four participating institutions: the CRG (the Centre for Genomic Regulation together with the National Centre for Genomic Analysis, CNAG), the IRB Barcelona (Institute for Research in Biomedicine), the IDIBAPS (August Pi i Sunyer Institute for Biomedical Research) and the VHIR (Vall d'Hebron Research Institute). Ultimately, the medical professionals enrolled in the program will obtain their PhD title from one of the associated Universities.

 

 

CALL OPEN
11 February 2016

 

 

REGISTRATION DEADLINE
11 April 2016

 

Alberto Indacochea, MD

Fellow of the 1st Edition of the PhD4MD

My video

From The News

Alt


"A clinical view is important to make sense of research and research is important to improve clinical practice.”


During her residency in the Psychiatric Service of the Vall d’Hebron University Hospital, Eva Calvo was drawn to some of the studies conducted by VHIR’s Psychiatry, Addictions and Mental Health Group, headed Dr. Miquel Casas, and became involved in them.

Alt


"Questions are raised when dealing with patients, but are answered in the laboratory."


Juan Miguel Cejalvo (Valencia, 1984), an oncologist trained at the Hospital Clínico Universitario de Valencia, has been selected to do his thesis at IRB Barcelona under the PhD for Medical Doctors (PhD4MD) programme. He has already joined Roger Gomis’ Growth Control and Cancer Metastasis group, where he will perform the basic research for his project. Aleix Prat, from IDIBAPS, will lead the clinical part.